Estimating long‐term treatment effects in observational data: A comparison of the performance of different methods under real‐world uncertainty
暂无分享,去创建一个
[1] James M Robins,et al. The International Journal of Biostatistics CAUSAL INFERENCE Dynamic Regime Marginal Structural Mean Models for Estimation of Optimal Dynamic Treatment Regimes , Part II : Proofs of Results , 2011 .
[2] Tyler J. VanderWeele,et al. Concerning the consistency assumption in causal inference. , 2009, Epidemiology.
[3] Donald B. Rubin,et al. Bayesian Inference for Causal Effects: The Role of Randomization , 1978 .
[4] Andrew Forbes,et al. Variance reduction in randomised trials by inverse probability weighting using the propensity score , 2013, Statistics in medicine.
[5] Stijn Vansteelandt,et al. A Note on G-Estimation of Causal Risk Ratios. , 2018, American journal of epidemiology.
[6] T. Schuster,et al. Effect Estimation in Point-Exposure Studies with Binary Outcomes and High-Dimensional Covariate Data – A Comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting , 2016, The international journal of biostatistics.
[7] B L De Stavola,et al. Methods for dealing with time‐dependent confounding , 2013, Statistics in medicine.
[8] Patrick Royston,et al. The design of simulation studies in medical statistics , 2006, Statistics in medicine.
[9] Sherri Rose,et al. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies , 2017, American journal of epidemiology.
[10] Mark J van der Laan,et al. History-adjusted marginal structural models for estimating time-varying effect modification. , 2007, American journal of epidemiology.
[11] J. Robins,et al. Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.
[12] S. Stanojevic,et al. Data Resource Profile: The UK Cystic Fibrosis Registry , 2017, International journal of epidemiology.
[13] Stijn Vansteelandt,et al. Structural nested models and G-estimation: the partially realized promise , 2014, 1503.01589.
[14] Sherri Rose,et al. Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. , 2011, American journal of epidemiology.
[15] Stephen R Cole,et al. Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.
[16] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[17] James M. Robins,et al. Estimation of Effects of Sequential Treatments by Reparameterizing Directed Acyclic Graphs , 1997, UAI.
[18] S. Vansteelandt,et al. Revisiting g-estimation of the Effect of a Time-varying Exposure Subject to Time-varying Confounding , 2016 .
[19] S. Nolan,et al. Dornase alfa for cystic fibrosis. , 2017, Paediatric respiratory reviews.
[20] S. Cole,et al. Estimating the Effect of Cumulative Occupational Asbestos Exposure on Time to Lung Cancer Mortality: Using Structural Nested Failure-Time Models to Account for Healthy-Worker Survivor Bias , 2014, Epidemiology.
[21] Eric B. Laber,et al. Dynamic treatment regimes: Technical challenges and applications , 2014 .
[22] J. Robins,et al. G-Estimation of the Effect of Prophylaxis Therapy for Pneumocystis carinii Pneumonia on the Survival of AIDS Patients , 1992, Epidemiology.
[23] M. J. van der Laan. Targeted Maximum Likelihood Based Causal Inference: Part I , 2010, The international journal of biostatistics.
[24] M. Petersen,et al. Diagnosing Bias in the Inverse Probability of Treatment Weighted Estimator Resulting from Violation of Experimental Treatment Assignment , 2006 .
[25] J. Robins. A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .
[26] Jessica G. Young,et al. Simulation from a known Cox MSM using standard parametric models for the g‐formula , 2014, Statistics in medicine.
[27] Romain Neugebauer,et al. Targeted learning in real‐world comparative effectiveness research with time‐varying interventions , 2014, Statistics in medicine.
[28] H. Fuchs,et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. , 1994, The New England journal of medicine.
[29] S. Vansteelandt,et al. Analysis of Longitudinal Studies With Repeated Outcome Measures: Adjusting for Time-Dependent Confounding Using Conventional Methods , 2017, American journal of epidemiology.